Human Immunodeficiency Virus (HIV)–Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy
暂无分享,去创建一个
S. Lewin | F. Hecht | P. Bacchetti | E. Sinclair | Matthew J. Gartner | S. Deeks | R. Fromentin | N. Chomont | C. L. Epling | M. Somsouk | P. Cameron | R. Hoh | Michael Roche | W. Hartogensis | J. Milush | Jenny L Anderson | M. Pitman | Gabriela Khoury | A. Solomon | C. Tumpach
[1] D. Kaufmann,et al. Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection , 2019, PLoS pathogens.
[2] H. Hatano,et al. Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency , 2018, PLoS pathogens.
[3] W. Paxton,et al. Blood CXCR3+ CD4 T Cells Are Enriched in Inducible Replication Competent HIV in Aviremic Antiretroviral Therapy-Treated Individuals , 2018, Front. Immunol..
[4] R. Balderas,et al. CTLA‐4+PD‐1− Memory CD4+ T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy‐Suppressed, SIV‐Infected Rhesus Macaques , 2017, Immunity.
[5] J. Lifson,et al. Defining total-body AIDS-virus burden with implications for curative strategies , 2017, Nature Medicine.
[6] Daniel I. S. Rosenbloom,et al. Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics , 2017, The Journal of experimental medicine.
[7] E. Bernasconi,et al. Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization , 2017, The Journal of Immunology.
[8] J. Routy,et al. HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy , 2016, AIDS.
[9] S. Lewin,et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART , 2016, PLoS pathogens.
[10] S. Lewin,et al. Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy , 2016, AIDS.
[11] G. Pantaleo,et al. PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals , 2016, Nature Medicine.
[12] T. Hope,et al. Th17 Cells Are Preferentially Infected Very Early after Vaginal Transmission of SIV in Macaques. , 2016, Cell host & microbe.
[13] P. Massip,et al. CCR6− regulatory T cells blunt the restoration of gut Th17 cells along the CCR6–CCL20 axis in treated HIV-1-infected individuals , 2016, Mucosal Immunology.
[14] Trevor Bedford,et al. Persistent HIV-1 replication maintains the tissue reservoir during therapy , 2015, Nature.
[15] Rebecca Hoh,et al. Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study. , 2015, The lancet. HIV.
[16] P. E. Van den Steen,et al. CXCR3 ligands in disease and therapy. , 2015, Cytokine & growth factor reviews.
[17] L. Picker,et al. A B cell follicle sanctuary permits persistent productive SIV infection in elite controllers , 2014, Nature Medicine.
[18] P. Gaulard,et al. Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients , 2014, Mucosal Immunology.
[19] G. D'offizi,et al. Quasispecies tropism and compartmentalization in gut and peripheral blood during early and chronic phases of HIV-1 infection: possible correlation with immune activation markers. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[20] H. Hatano,et al. Occurrence of etravirine/rilpivirine-specific resistance mutations selected by efavirenz and nevirapine in Kenyan patients with non-B HIV-1 subtypes failing antiretroviral therapy , 2014, AIDS.
[21] Alan S Perelson,et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues , 2014, Proceedings of the National Academy of Sciences.
[22] J. Arthos,et al. Preferential HIV Infection of CCR6+ Th17 Cells Is Associated with Higher Levels of Virus Receptor Expression and Lack of CCR5 Ligands , 2013, Journal of Virology.
[23] S. McColl,et al. A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system. , 2013, Cytokine & growth factor reviews.
[24] Antonio Lanzavecchia,et al. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. , 2012, Blood.
[25] Cheng Li,et al. A Plasma Biomarker Signature of Immune Activation in HIV Patients on Antiretroviral Therapy , 2012, PloS one.
[26] R. Dewar,et al. Lack of compartmentalization of HIV-1 quasispecies between the gut and peripheral blood compartments. , 2011, The Journal of infectious diseases.
[27] J. Fontaine,et al. Short communication: persistence of high blood levels of the chemokines CCL2, CCL19, and CCL20 during the course of HIV infection. , 2011, AIDS research and human retroviruses.
[28] J. Routy,et al. Memory CCR6+CD4+ T Cells Are Preferential Targets for Productive HIV Type 1 Infection Regardless of Their Expression of Integrin β7 , 2011, The Journal of Immunology.
[29] L. Agosto,et al. HIV reservoirs and latency models. , 2011, Virology.
[30] Toshihiro Ito,et al. CCR6 as a mediator of immunity in the lung and gut. , 2011, Experimental cell research.
[31] C. B. Hare,et al. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. , 2010, The Journal of infectious diseases.
[32] G. Boucher,et al. Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton , 2010, Proceedings of the National Academy of Sciences.
[33] S. Jensen-Fangel,et al. Phylogeny and resistance profiles of HIV‐1 POL sequences from rectal biopsies and blood , 2010, Journal of medical virology.
[34] W. Borkowsky,et al. Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. , 2010, The Journal of infectious diseases.
[35] J. Routy,et al. Peripheral Blood CCR4+CCR6+ and CXCR3+CCR6+ CD4+ T Cells Are Highly Permissive to HIV-1 Infection , 2009, The Journal of Immunology.
[36] M. Juan,et al. Chemokines and Chemokine Receptors , 2009 .
[37] Carole R. Baskin,et al. Critical Loss of the Balance between Th17 and T Regulatory Cell Populations in Pathogenic SIV Infection , 2009, PLoS pathogens.
[38] D. Douek,et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. , 2008, Blood.
[39] D. Douek,et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques , 2008, Mucosal Immunology.
[40] D. Nickle,et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. , 2008, The Journal of infectious diseases.
[41] Chen Dong,et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. , 2008, Immunity.
[42] Suha M. Saleh,et al. CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency. , 2007, Blood.
[43] R. D. de Boer,et al. Do Most Lymphocytes in Humans Really Reside in the Gut? , 2022 .
[44] T. Nomura,et al. Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .
[45] Laurie H Glimcher,et al. A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment , 2000, Cell.
[46] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[47] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[48] R. Siliciano,et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.
[49] R. Pabst,et al. Distribution of lymphocyte subsets and natural killer cells in the human body , 1992, The clinical investigator.
[50] S. Lewin,et al. HIV persistence and T-cell activation in blood, rectal and lymph node tissue in HIV-infected individuals receiving suppressive ART. , 2017, The Journal of infectious diseases.